Drawing for CREATING DRUGS AT THE SPEED OF AI

USPTO serial 99137351

CREATING DRUGS AT THE SPEED OF AI

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
SOUNDAR, SHERYL CHRISTINA
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with CREATING DRUGS AT THE SPEED OF AI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*

Plus Government fees of $300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tiffany D. Gehrke

Tiffany D. Gehrke Marshall, Gerstein & Borun LLP233 South Wacker Drive, Suite 6300Chicago, IL 60606United States

Goods and services

ClassDescriptionStatusFirst use
040Biotechnological services in the nature of custom biomanufacturing of pharmaceutical preparations, namely, custom production and purification of biotechnological and pharmaceutical preparations, namely, hormones, antibodies, and proteins; biotechnological services in the nature of custom biomanufacturing of pharmaceutical preparations, namely, custom production of cell lines to produce proteins, namely, hormones, cytokines, antibodies and antibody fragmentsACTIVE—
042Scientific and technological consulting services relating to producing, assaying, and purifying biotechnological products; research and development in the pharmaceutical and biotechnology fields; biotechnical and pharmacological laboratory services for biomanufacturing, namely, scientific and technological research relating to the production of biotechnological products for use in preparing pharmaceutical preparations; scientific and technological research, namely, scientific research, development, analysis, producing, testing, in the field of biotechnology, namely, production of biotechnological products for use in preparing pharmaceutical preparations, and scientific research consultation related thereto; scientific research, namely, carrying out feasibility studies relating to the production of biotechnological products for use in preparing pharmaceutical preparations; development of pharmaceutical preparations, medicines and medicaments; technological consultancy services, namely, technological consultation in the field of biotechnology, namely, production of biotechnological products for use in preparing pharmaceutical preparations; Bioinformatics research services, namely, analyzing complex biological data through the use of artificial intelligence, and testing and evaluation of biologics through artificial intelligence; development of pharmaceutical preparations in the nature of computer assisted biologics design involving the use of artificial intelligence technology; Biotechnological services, namely, development of biotechnological and pharmaceutical preparations, namely, hormones, antibodies, and proteins; biotechnological services, namely, development of cell lines to produce proteins, namely, hormones, cytokines, antibodies and antibody fragmentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Jul 7, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 12, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 12, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 6, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 17, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 8, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Apr 8, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 8, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 8, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 9, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Dec 9, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Dec 8, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 8, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 8, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 10, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2025DOCKASSIGNED TO EXAMINER—
Jul 11, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 15, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 15, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance